Accesswire
18 May 2026, 06:05 UTC · 3d ago
Source · https://www.accessnewswire.com/newsroom/en/agriculture/agronomics-limited-announces-net-asset-value-calculation-as-at-31-march-2026-1167667
Read source
Story key points
5 claims · impact-rated
Agronomics Limited's NAV per share fell 4.8% to 13.12 pence as of 31 March 2026, reflecting a £1.3 million decrease in net assets during the quarter. — A quarterly decline in NAV directly signals a reduction in the intrinsic value of the company's investment portfolio, negatively affecting valuations for the stock and its underlying holdings.
-0.50Tropic Biosciences UK Limited closed a US$105 million Series C financing round co-led by Forbion and Corteva. — A major funding round backed by prominent agricultural and venture capital partners validates Tropic's technology and provides substantial capital to scale operations, materially de-risking Agronomics' largest holding.
+0.45The company's shares traded at a 52% discount to NAV as of 31 March 2026, slightly wider than the 12-month average discount of 50%. — A widening discount to NAV signals growing investor skepticism regarding the portfolio's fair value and liquidity, exerting downward pressure on the stock's risk premium.
-0.40Search tags
Portfolio company Clean Food Group achieved the commercial launch of its CLEANOil™ ingredient platform in collaboration with manufacturer THG Labs. — Transitioning from development to commercial revenue generation validates the technology's market viability and represents a critical de-risking milestone for the investment.
+0.35Agronomics made an additional AU$3 million investment in All G Co Holdings, funded by issuing over 10 million new shares at 14.65 pence per share. — Issuing new shares at a premium to the current trading price but at a discount to NAV dilutes existing shareholders and erodes the per-share asset backing.
-0.25Impact vectors
2 dimensions · 9 clusters
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Ticker attribution
Model heads
The company reported a 4.8% decrease in Net Asset Value per share and a high discount to NAV.
Corteva co-led a successful US$105 million Series C financing round for portfolio company Tropic Biosciences.
